Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder

Neuroscience Letters

Volumn 475, Issue 2, 2010, Pages 95-98

  Barbosa, Izabela Guimarães ^a,b   Huguet, Rodrigo Barreto ^a,b   Mendonça, Vanessa Amaral ^a   Neves, Fernando Silva ^a   Reis, Helton José ^a   Bauer, Moisés Evandro ^c   Janka, Zoltán ^d   Palotás, András ^e   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Governador Israel Pinheiro   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SZEGED   (Hungary)

^e Asklepios Med Private Practice and Research Center   (Hungary)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor; Mania; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; BIPOLAR DISORDER; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRUCTURED INTERVIEW; YOUNG MANIA RATING SCALE;

ADULT; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 77952888840     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.03.055     Document Type: Article

References (26)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, D.C. 4th ed.
2. Amorim P. Mini international neuropsychiatric interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev. Bras. Psiquiatr. 2000, 22:106-115.
3. Belmaker R.H. Bipolar disorder. N. Engl. J. Med. 2004, 351:476-486.
4. Cunha A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Gonçalves C.A., Santin A., Kapczinski F. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 2006, 398:215-219.
5. de Oliveira G.S., Ceresér K.M., Fernandes B., Kauer-Sant'anna M., Fries G.R., Stertz L., Aguiar B., Pfaffenseller B., Kapczinski F. Descreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J. Psychiatr. Res. 2009, 43:1171-1174.
6. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 33:7311-7316.
7. Gama C.S., Andreazza A.C., Kunz M., Berk M., Belmonte-de-Abreu P.S., Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci. Lett. 2007, 420:45-48.
8. Grassi-Oliveira R., Stein L.M., Lopes R.P., Teixeira A.L., Bauer M.E. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression-a preliminary report. Biol. Psychiatry 2008, 64:281-285.
9. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
10. Kauer-Sant'Anna M., Kapczinski F., Andreazza A.C., Bond D.J., Lam R.W., Young L.T., Yatham L.N. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int. J. Neuropsycopharmacol. 2009, 12(4):447-458.
11. Machado-Vieira R., Dietrich M.O., Leke R., Cereser V.H., Zanatto V., Kapczinski F., Souza D.O., Portela L.V., Gentil V. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Psychiatry 2007, 61:142-144.
12. Mackin P., Gallagher P., Watson S., Young A.H., Ferrier N. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. Aust. N. Z. J. Psychiatry 2007, 41:321-326.
13. Manji H.K., Moore G.J., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry 2000, 5:578-593.
14. Monteleone P., Serritella C., Martiadis V., Maj M. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 2008, 10:95-100.
15. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., Funato H., Watanabe Y. Altered expression of neurotrophic factors in patients with major depression. J. Psychiatr. Res. 2008, 42:1145-1153.
16. Pandey G.N., Rizavi H.S., Dwivedi Y., Pavuluri M.N. Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:1077-1085.
17. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., Mannari C., Martini C., Da Pozzo E., Schiavi E., Mariotti A., Roncaglia I., Palla A., Consoli G., Giovannini L., Massimetti G., Dell'Osso L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect Disord. 2008, 105:279-283.
18. Pillai A., Terry A.V., Mahadik S.P. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr. Res. 2006, 82:95-106.
19. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 2007, 41:979-990.
20. Reis H.J., Nicolato R., Barbosa I.G., Teixeira do Prado P.H., Romano-Silva M.A., Teixeira A.L. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci. Lett. 2008, 439:157-159.
21. Schulte-Herbrüggen O., Eckart S., Deicke U., Kühl A., Otten U., Danker-Hopfe H., Abramowski D., Staufenbiel M., Hellweg R. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice. J. Neurosci. Res. 2008, 86:2774-2783.
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-international neuro-psychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:4-57.
23. Tramontina J.F., Andreazza A.C., Kauer-Sant'Anna M., Stertz L., Goi J., Chiarani F., Kapczinski F. Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci. Lett. 2009, 452:111-113.
24. Yoshimura R., Nakano Y., Hori H., Ikenouchi A., Ueda N., Nakamura J. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Hum. Psychopharmacol. Clin. Exp. 2006, 21:433-438.
25. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
26. Zarate C.A., Singh J., Manji H.K. Cellular plasticity cascades: targets for the development of novels therapeutics for bipolar disorder. Biol. Psychiatry 2006, 59:1006-1020.